bisbenzimidazole has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karami-Tehrani, F; Salami, S | 1 |
| Fujita, S; Ishizaka, M; Kazusaka, A; Kim, HS | 1 |
2 other study(ies) available for bisbenzimidazole and tamoxifen
| Article | Year |
|---|---|
Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines.
Topics: Annexin A5; Antineoplastic Agents, Hormonal; Apoptosis; bcl-2-Associated X Protein; Bisbenzimidazole; Breast Neoplasms; Caspase 3; Caspase Inhibitors; Caspases; Cell Division; Cell Line, Tumor; Enzyme Activation; Female; Flow Cytometry; Fluorescent Dyes; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Tamoxifen | 2003 |
Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Bisbenzimidazole; Blotting, Western; Cell Line, Tumor; Cell Survival; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flow Cytometry; Microscopy, Fluorescence; Pituitary Neoplasms; Plasticizers; Poly(ADP-ribose) Polymerases; Tamoxifen | 2007 |